Referenser och regelverk

    Innehållet är grundat på beprövad erfarenhet, lagar, regelverk, nationella riktlinjer och med stöd från relevanta vetenskapliga studier.  

    Referenser

    1. Acosta S, Frykholm P, Granath A, Hammarskjöld F, Lindgren S, Lindwall R, Pikwer A, Sandström K, Taxbro K, Åkeson J. Riktlinjer för central venkateterisering. Svensk förening för anestesi och intensivvård (SFAI); 2018.
    2. Infektioner vid centrala venösa infarter : åtgärder för att förebygga. Stockholm: Sveriges Kommuner och Regioner (SKR); 2011.
    3. Tanner J, Moncaster K, Woodings D. Preoperative hair removal: a systematic review. J Perioper Pract. 2007;17(3):118-21, 24-32.
    4. Evidence review for the effectiveness of skin antiseptics in the prevention of surgical site infection. NICE guideline NG125. Surgical site infection: prevention and treatment. [B]; April 2019.
    5. Carr PJ , Higgins NS, Cooke ML, Mihala G, Rickard CM. Vascular access specialist teams for device insertion and prevention of failure. Cochrane Database Syst Rev.. 2018;3(3):
    6. O'Grady NP, Alexander M, Burns LA, Dellinger EP, Garland J, Heard SO, et al. Guidelines for the prevention of intravascular catheter-related infections. Clin Infect Dis. 2011;52(9):e:162-63.
    7. Lebeaux et al.. Management of infections related to totally implantable venous-access ports: challenges and perspectives.. Lancet Infect Dis.. 2014;14(2):146-59.
    8. Pittiruti M, Bertoglio S, Scoppettuolo G, Biffi R, Lamperti M, Dal Molin A, Panocchia N, Petrosillo N, Venditti M, Rigo C, DeLutio E. Evidence-based criteria for the choice and the clinical use of the most appropriate lock solutions for central venous catheters (excluding dialysis catheters): a GAVeCeLT consensus. J Vasc Access. 2016;17(6):453-464.
    9. Guiffant G, Durussel JJ, Flaud P, Vigier JP, Merckx J. Flushing ports of totally implantable venous access devices, and impact of the Huber point needle bevel orientation: experimental tests and numerical computation. Med Devices (Auckl). 2012;5:31-37.
    10. Breimer L H, Geijer H, Berggren L. Desinfektion av injektionsportar - 15 sekunders skrubbning rimligt (pdf). Läkartidningen. 2018;115:1-4.
    11. López-Briz E , Ruiz Garcia V, Cabello JB,Bort-Martí S,Carbonell Sanchis R,Burls A. Heparin versus 0,9 % sodium chloride locking for prevention of occlusion in central venous catheters in adults.. Cochrane Database Syst Rev.. 2018;7(7):
    12. Bradford N K, Edwards R M, Chan R J.. Normal saline (0,9 % sodium chloride) versus heparin intermittent flushing for the prevention of occlusion in long-term central venous catheters in infants and children.. Cochrane Database Syst Rev.. 2020;4(4):
    13. Clari M , Spoto M, Franceschi G, Acuto M, Tonella S ,Caristia S, Buratti G, Gaboardi S, Rasero L, Campagna S, Busca E, Dal Molin A. Short Versus Long Timing of Flushing of Totally Implantable Venous Access Devices When Not Used Routinely.. Cancer Nurs.. 2021;44:205-213.
    14. Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med. 2004;140(1):18-25.
    15. Pronovost P. Interventions to decrease catheter-related bloodstream infections in the ICU: the Keystone Intensive Care Unit Project. Am J Infect Control. 2008;36(10):S171 e 1-5.
    16. Warren DK, Yokoe DS, Climo MW, Herwaldt LA, Noskin GA, Zuccotti G, et al. Preventing catheter-associated bloodstream infections: a survey of policies for insertion and care of central venous catheters from hospitals in the prevention epicenter program. Infect Control Hosp Epidemiol. 2006;27(1):8-13.
    17. Blanco-Guzman M O. Implanted vascular access device options: a focused review on safety and outcomes.. Transfusion. 2018;58 Suppl 1:558-568.
    18. Tabatabaie O , Kasumova GG, Eskander MF, Critchlow JF, Tawa NE, Tseng JF. Totally Implantable Venous Access Devices: A review of Complications and Management Strategies. Am J Clin Oncol. 2017;40(1):94-105.
    19. Mermel LA, Allon M, Bouza E, Craven DE, Flynn P, O'Grady NP, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1-45.
    20. Pittiruti M, Hamilton H, Biffi R, MacFie J, Pertkiewicz M. ESPEN Guidelines on Parenteral Nutrition: central venous catheters (access, care, diagnosis and therapy of complications). Clin Nutr. 2009;28(4):365-77.
    21. Visek J, Ryskova L, Safranek R, Lasticova M, Blaha V.. In vitro comparison of efficacy of catheter locks in the treatment of catheter related blood stream infection. Clin Nutr ESPEN. 2019;apr;30:107-112.

    Övriga referenser

    Regelverk

    Revideringsdatum:
    2022-01-12
    Författare:
    Jimmy Almström, Specialistläkare, VO Anestesi, Operation och Intensivvård, Akademiska sjukhuset, UppsalaKajsa Wågström, Specialistsjuksköterska Onkologisk vård, VO Blod- och tumörsjukdomar/Sektion Onkologisk vård, Akademiska sjukhuset, Uppsala
    Faktagranskare:
    Fredrik Smith, Specialistläkare, AnOpIva, Sahlgrenska Universitetssjukhuset, Göteborg
    Till toppen av sidan